COVID-19 treatment breakthroughs: Expert webinar tonight on the latest on therapies

October 13, 2020

Want to learn more about the antibody cocktail used on President Trump, and other treatments being developed? Tune in tonight for the free COVID-19 treatments webinar.

Want to learn more about the antibody cocktail used on President Trump, and other treatments being developed? Tune in tonight for the free webinar on the latest and greatest concerning COVID-19 treatments.

As the COVID-19 pandemic continues to work its way through the country the treatment landscape continues to shift seemingly by the day.

To clear the confusion on what helps and what hurts patients the MJH Life Sciences COVID-19 Coalition will host a free webinar tonight, Oct. 13, at 6 p.m. EDT, titled “Navigating the COVID-19 Treatment Landscape." The program will feature a trio of experts discussing the latest in antivirals, anti-inflammatory therapies, corticosteroids, and convalescent plasma.

Click here to register for the free webinar.

The experts will help you stay up to speed on all the current agents in the physician’s arsenal to combat COVID-19.

Participants in this webinar will be:

  • Moderator Jason M. Pogue, PharmD, BCPS, BCIDP, a clinical professor at the University of Michigan College of Pharmacy and an infectious diseases clinical pharmacist at Michigan Medicine. His research interests focus on epidemiology and management of multi-drug resistant Gram-negative organisms and antimicrobial stewardship.
  • Panelist Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, a clinical professor at Temple University School of Pharmacy and clinical pharmacy specialist at Temple University Hospital where he maintains a clinical practice. He is currently the president of the Society of Infectious Diseases Pharmacists and the editor-in-chief of Contagion.
  • Panelist Susan Davis, PharmD, a clinical professor of pharmacy practice at Wayne State University with a joint appointment as infectious diseases pharmacy specialist at Henry Ford Health System. She has published more than 80 peer-reviewed manuscripts in the field of antimicrobial pharmacotherapy.